Clinical Trial Update: Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud [EARLY_Phase 1]

View source ↗

Summary

The document notes completion of an early Phase 1 trial comparing topical 10% nifedipine with 5% sildenafil for secondary Raynaud's phenomenon, with no results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Raynaud Disease
• Raynaud Phenomenon
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• Topical nifedipine (nifedipine)
• Topical sildenafil (sildenafil)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Raynaud Phenomenon Due to Trauma, Raynaud Disease | EARLY_Phase 1 | Status: COMPLETED